EFFECT OF PENETRATION ENHANCERS (PYRROLIDONE DERIVATIVES) ON MULTILAMELLAR LIPOSOMES OF STRATUM-CORNEUM LIPID - A STUDY BY UV SPECTROSCOPY AND DIFFERENTIAL SCANNING CALORIMETRY

被引:27
作者
KIM, CK [1 ]
HONG, MS [1 ]
KIM, YB [1 ]
HAN, SK [1 ]
机构
[1] PUSAN NATL UNIV, COLL PHARM, PUSAN 609735, SOUTH KOREA
关键词
STRATUM-CORNEUM LIPID LIPOSOME; PENETRATION ENHANCER; PYRROLIDONE DERIVATIVE; OSMOTIC BEHAVIOR; LIPID FLUIDITY; DSC;
D O I
10.1016/0378-5173(93)90388-V
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In order to elucidate the mechanisms of action of transdermal absorption-enhancing compounds, i.e., pyrrolidone derivatives (1-methyl-2-pyrrolidone, 1-ethyl-2-pyrrolidone, 1,5-dimethyl-2-pyrrolidone, 5-methyl-2-pyrrolidone), multilamellar liposome was prepared from the simulated stratum corneum lipids and employed as a model system for the barrier function of the stratum corneum. The liposomal membrane of the stratum corneum lipid liposome (SCLL) behaves as an osmometer and has an excellent barrier function. In addition, its phase transition temperatures are similar to those of human stratum corneum intercellular lipid region. Therefore, SCLL seems to be a useful skin model. The effect of the pyrrolidone derivatives on the osmotic behavior of SCLL was examined. As the result of the osmotic behaviors, pyrrolidone derivatives perturb the barrier function of the liposome. The more hydrophobic enhancers penetrate more easily into the lipid bilayer and reduce the barrier function of the membrane more effectively. The results of differential scanning thermograms of the SCLL suggest that the pyrrolidone derivatives had incorporated into the lipid layer in the liposome and increased the fluidity of the lipid layer in the liposome and such activity might have some correlation with the transdermal absorption-enhancing activity of these compounds.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 33 条
[1]   ABSORPTION THROUGH HUMAN-SKIN OF IBUPROFEN AND FLURBIPROFEN - EFFECT OF DOSE VARIATION, DEPOSITED DRUG FILMS, OCCLUSION AND THE PENETRATION ENHANCER N-METHYL-2-PYRROLIDONE [J].
AKHTER, SA ;
BARRY, BW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (01) :27-37
[2]   ENHANCEMENT OF NALOXONE PENETRATION THROUGH HUMAN-SKIN INVITRO USING FATTY-ACIDS, FATTY ALCOHOLS, SURFACTANTS, SULFOXIDES AND AMIDES [J].
AUNGST, BJ ;
ROGERS, NJ ;
SHEFTER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :225-234
[3]  
Bangham a. D., 1967, CHEM PHYS LIPIDS, V1, P225, DOI DOI 10.1016/0009-3084(67)90030-8
[4]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[5]  
BARRY BW, 1983, DERMATOLOGICAL FORMU, P127
[6]  
BARRY BW, 1987, DRUG DELIVERY SYSTEM, P200
[7]   MECHANISM OF ACTION OF AZONE AS A PERCUTANEOUS PENETRATION ENHANCER - LIPID BILAYER FLUIDITY AND TRANSITION-TEMPERATURE EFFECTS [J].
BEASTALL, JC ;
HADGRAFT, J ;
WASHINGTON, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (03) :207-213
[8]   OSMOTIC BEHAVIOR OF LIPOSOMES OF PHOSPHATIDYLCHOLINE AND PHOSPHATIDYLSULFOCHOLINE AS A FUNCTION OF LIPID-CONCENTRATION [J].
BITTMAN, R ;
LEVENTHAL, AM ;
KARP, S ;
BLAU, L ;
TREMBLAY, PA ;
KATES, M .
CHEMISTRY AND PHYSICS OF LIPIDS, 1981, 28 (04) :323-335
[9]  
CHEIN TW, 1987, TRANDERMAL CONTROLLE, P25
[10]   CELLULAR ARCHITECTURE OF STRATUM CORNEUM [J].
CHRISTOPHERS, E .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1971, 56 (03) :165-+